Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice

There has been increasing interest in adjunctive use of anti-inflammatory drugs to control periodontitis. This study was performed to examine the effects of pirfenidone (PFD) on alveolar bone loss in ligature-induced periodontitis in mice and identify the relevant mechanisms. Experimental periodonti...

Full description

Bibliographic Details
Main Authors: Zijiao Zhang, Juhan Song, Seung-Hee Kwon, Zhao Wang, Suk-Gyun Park, Xianyu Piao, Je-Hwang Ryu, Nacksung Kim, Ok-Su Kim, Sun-Hun Kim, Jeong-Tae Koh
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/10/8682
_version_ 1797599780597137408
author Zijiao Zhang
Juhan Song
Seung-Hee Kwon
Zhao Wang
Suk-Gyun Park
Xianyu Piao
Je-Hwang Ryu
Nacksung Kim
Ok-Su Kim
Sun-Hun Kim
Jeong-Tae Koh
author_facet Zijiao Zhang
Juhan Song
Seung-Hee Kwon
Zhao Wang
Suk-Gyun Park
Xianyu Piao
Je-Hwang Ryu
Nacksung Kim
Ok-Su Kim
Sun-Hun Kim
Jeong-Tae Koh
author_sort Zijiao Zhang
collection DOAJ
description There has been increasing interest in adjunctive use of anti-inflammatory drugs to control periodontitis. This study was performed to examine the effects of pirfenidone (PFD) on alveolar bone loss in ligature-induced periodontitis in mice and identify the relevant mechanisms. Experimental periodontitis was established by ligating the unilateral maxillary second molar for 7 days in mice (n = 8 per group), and PFD was administered daily via intraperitoneal injection. The micro-computed tomography and histology analyses were performed to determine changes in the alveolar bone following the PFD administration. For in vitro analysis, bone marrow macrophages (BMMs) were isolated from mice and cultured with PFD in the presence of RANKL or LPS. The effectiveness of PFD on osteoclastogenesis, inflammatory cytokine expression, and NF-κB activation was determined with RT-PCR, Western blot, and immunofluorescence analyses. PFD treatment significantly inhibited the ligature-induced alveolar bone loss, with decreases in TRAP-positive osteoclasts and expression of inflammatory cytokines in mice. In cultured BMM cells, PFD also inhibited RANKL-induced osteoclast differentiation and LPS-induced proinflammatory cytokine (IL-1β, IL-6, TNF-a) expression via suppressing the NF-κB signal pathway. These results suggest that PFD can suppress periodontitis progression by inhibiting osteoclastogenesis and inflammatory cytokine production via inhibiting the NF-κB signal pathway, and it may be a promising candidate for controlling periodontitis.
first_indexed 2024-03-11T03:40:11Z
format Article
id doaj.art-08f71deed57c4d13bf7b28db0b29c18a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:40:11Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-08f71deed57c4d13bf7b28db0b29c18a2023-11-18T01:39:52ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012410868210.3390/ijms24108682Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in MiceZijiao Zhang0Juhan Song1Seung-Hee Kwon2Zhao Wang3Suk-Gyun Park4Xianyu Piao5Je-Hwang Ryu6Nacksung Kim7Ok-Su Kim8Sun-Hun Kim9Jeong-Tae Koh10Department of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaHard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaHard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaHard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaDepartment of Pharmacology and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of KoreaThere has been increasing interest in adjunctive use of anti-inflammatory drugs to control periodontitis. This study was performed to examine the effects of pirfenidone (PFD) on alveolar bone loss in ligature-induced periodontitis in mice and identify the relevant mechanisms. Experimental periodontitis was established by ligating the unilateral maxillary second molar for 7 days in mice (n = 8 per group), and PFD was administered daily via intraperitoneal injection. The micro-computed tomography and histology analyses were performed to determine changes in the alveolar bone following the PFD administration. For in vitro analysis, bone marrow macrophages (BMMs) were isolated from mice and cultured with PFD in the presence of RANKL or LPS. The effectiveness of PFD on osteoclastogenesis, inflammatory cytokine expression, and NF-κB activation was determined with RT-PCR, Western blot, and immunofluorescence analyses. PFD treatment significantly inhibited the ligature-induced alveolar bone loss, with decreases in TRAP-positive osteoclasts and expression of inflammatory cytokines in mice. In cultured BMM cells, PFD also inhibited RANKL-induced osteoclast differentiation and LPS-induced proinflammatory cytokine (IL-1β, IL-6, TNF-a) expression via suppressing the NF-κB signal pathway. These results suggest that PFD can suppress periodontitis progression by inhibiting osteoclastogenesis and inflammatory cytokine production via inhibiting the NF-κB signal pathway, and it may be a promising candidate for controlling periodontitis.https://www.mdpi.com/1422-0067/24/10/8682pirfenidoneperiodontitisosteoclast differentiationalveolar bone lossinflammationNF-κB pathway
spellingShingle Zijiao Zhang
Juhan Song
Seung-Hee Kwon
Zhao Wang
Suk-Gyun Park
Xianyu Piao
Je-Hwang Ryu
Nacksung Kim
Ok-Su Kim
Sun-Hun Kim
Jeong-Tae Koh
Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
International Journal of Molecular Sciences
pirfenidone
periodontitis
osteoclast differentiation
alveolar bone loss
inflammation
NF-κB pathway
title Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
title_full Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
title_fullStr Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
title_full_unstemmed Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
title_short Pirfenidone Inhibits Alveolar Bone Loss in Ligature-Induced Periodontitis by Suppressing the NF-κB Signaling Pathway in Mice
title_sort pirfenidone inhibits alveolar bone loss in ligature induced periodontitis by suppressing the nf κb signaling pathway in mice
topic pirfenidone
periodontitis
osteoclast differentiation
alveolar bone loss
inflammation
NF-κB pathway
url https://www.mdpi.com/1422-0067/24/10/8682
work_keys_str_mv AT zijiaozhang pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT juhansong pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT seungheekwon pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT zhaowang pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT sukgyunpark pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT xianyupiao pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT jehwangryu pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT nacksungkim pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT oksukim pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT sunhunkim pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice
AT jeongtaekoh pirfenidoneinhibitsalveolarbonelossinligatureinducedperiodontitisbysuppressingthenfkbsignalingpathwayinmice